MPP⁺ Neuronal Cell Death Assay Service
Advance your Parkinson's disease (PD) research with our efficient and accurate MPP+-induced neuronal cell death detection solutions. We empower researchers to gain deeper insights into the disease's pathogenesis and accelerate the screening of potential therapeutic drugs. For further information regarding the products and services provided, project-specific consultation, and pricing, please submit an inquiry here.
Introduction
Distributed under Open Access license CC BY-SA 4.0, from Wiki,
without modification.
MPP+ (1-methyl-4-phenylpyridinium ion) is a metabolite of MPTP (1-methyl-4-phenyl-2,3,6,7-tetrahydropyridine) and an important neurotoxin in PD research. It mainly enters dopaminergic neurons through the dopamine transporter (DAT) and accumulates inside the cells, inhibiting the mitochondrial electron transport chain complex I, leading to ATP depletion, increased production of reactive oxygen species (ROS), and cell death. In addition, MPP+ also induces the death of dopaminergic neurons through the combined action of oxidative stress and specific neurotoxins.
Our MPP+ Neuronal Cell Death Assays
- Advanced Modeling System
Human iPSC-derived Neurons: Utilizing human induced pluripotent stem cell (iPSC)-derived neurons to create more physiologically relevant models and study the impact of genetic variability on MPP+ toxicity.
Co-culture Systems: Incorporating multiple cell types, such as astrocytes and microglia, to recreate the complex cellular environment of the brain and study cell-cell interactions in neurotoxicity.
Controllable Conditions: Our MPP+-induced neuronal cell death platform offers unparalleled control over experimental conditions. By manipulating key environmental factors, we can distinguish between apoptotic and non-apoptotic cell death modes, providing critical insights for developing targeted therapies.
Fig.1 Representative images of primary mouse cortical tri-culture, NeuN (neuronal marker), GFAP (astrocyte marker) and Iba1 (microglia marker). Images acquired using Zeiss LSM 980.
- Comprehensive Detection Indicators
Cell Viability and Morphology: Quantify cell survival rates and apoptotic features using MTT assays and Hoechst/PI double staining, precisely reflecting neuronal damage across MPP⁺ concentration gradients.
Mitochondrial Dysfunction: Assess mitochondrial health by measuring ROS levels, cytochrome c release, and changes in mitochondrial membrane potential, key indicators of mitochondrial dysfunction.
Programmed Cell Death Pathways: Investigate the activation of key cell death pathways, including Caspase-3 activation (apoptosis), AIF nuclear translocation (caspase-independent apoptosis), and LC3-II accumulation (autophagy).
Calcium Signaling Dysregulation: Monitor MPP+-induced Ca2+ overload and its association with lysosomal dysfunction using fluorescent probes, revealing the interplay between calcium signaling and neurodegeneration.
Fig.2 Fluorescence detection of intracellular reactive oxygen species.1
- High Throughput Detection Platform
Our MPP+-induced neuronal cell death platform is optimized for high-throughput screening, enabling researchers to efficiently evaluate the effects of multiple compounds on neurodegeneration. We support both 96-well and 384-well plate formats, allowing for rapid and cost-effective screening of large compound libraries.
Our MPP+ neuronal cell death assay service is your trusted partner in the fight against neurodegeneration. We provide comprehensive support, cutting-edge technology, and expert analysis to accelerate your research and drive the development of innovative therapies. Please contact us and let us work together.
Reference
- Lu, Xi-Lin, et al. "Paeonolum protects against MPP+-induced neurotoxicity in zebrafish and PC12 cells." BMC Complementary and Alternative Medicine 15 (2015): 1-10. Distributed under Open Access license CC BY 4.0, without modification.
- iNeuMab™ Anti-Alpha Synuclein BBB Shuttle Antibody (NRZP-1022-ZP4050) (Cat#: NRZP-1022-ZP4050)
- iNeuMab™ Anti-CD20 Antibody (NRP-0422-P1230) (Cat#: NRP-0422-P1230)
- iNeuMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P1684) (Cat#: NRP-0422-P1684)
- iNeuMab™ Rabbit Anti-LRRK2 Monoclonal Antibody (CBP1887) (Cat#: NAB-08-PZ735)
- iNeuMab™ Mouse Anti-LRP1 Monoclonal Antibody (CBP3363) (Cat#: NAB-0720-Z6479)
- iNeuMab™ Anti-SEZ6 Antibody (NRP-0422-P517) (Cat#: NRP-0422-P517)
- iNeuMab™ Anti-TREM2 BBB Shuttle Antibody (NRZP-1022-ZP4114) (Cat#: NRZP-1022-ZP4114)
- iNeuMab™ Anti-Integrin αvβ8 BBB Shuttle Antibody (NRZP-1222-ZP1218) (Cat#: NRZP-1222-ZP1218)
- Rat Schwann Cells RSC96, Immortalized (Cat#: NCL-2108P21)
- Rat Retinal Muller Cell Line, Immortalized (Cat#: NCL-21P6-192)
- Green Fluorescent BACE1 Cell Lines (Cat#: NCL2110P214)
- Human Brain Astroblastoma U-87 MG (Cat#: NCL2110P117)
- Green Fluorescent Alpha-synuclein Cell Line (Cat#: NCL2110P209)
- Human Glial (Oligodendrocytic) Hybrid Cell Line (MO3.13) (Cat#: NCL-2108P34)
- Human Blood Brain Barrier Model (Cat#: NCL-2103-P187)
- Mouse Midbrain Dopaminergic Neuron Cell MN9D (Cat#: NCL2110P059)
- Mouse Glioma Cell Line GL261-GFP (Cat#: NCL-2108P04)
- Immortalized Human Cerebral Microvascular Endothelial Cells (Cat#: NCL-2108-P020)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)